Xiaolin Zhang

Dr. Xiaolin Zhang

The Department of Pharmacy, School of life and Health Sciences, Anhui Science and Technology University,
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2016 in Molecules
Verified
Journal Article
Open access
PDF file
XZXiaolin Zhang
Xiaolin Zhang
AJAnmin Jiang
Anmin Jiang
HYHao Yu
Hao Yu
YXYouyi Xiong
Youyi Xiong
GZGuoliang Zhou
Guoliang Zhou
JWJianfei Wang
Jianfei Wang
Metronidazole (MNZ) is an effective agent that has been employed to eradicate Helicobacter pylori (H. pylori). The emergence of broad MNZ resistance in H. pylori has affected the efficacy of this therapeutic agent. The concentration of MNZ, especially the mutant prevention concentration (MPC), plays an important role in selecting or enriching resistant mutants and regulating therapeutic effects. A strategy to reduce the MPC that can not only effectively treat H. pylori but also prevent resistance mutations is needed. H. pylori is highly resistant to lysozyme. Lysozyme possesses a hydrolytic bacterial cell wall peptidoglycan and a cationic dependent mode. These effects can increase the permeability of bacterial cells and promote antibiotic absorption into bacterial cells. In this study, human lysozyme (hLYS) was used to probe its effects on the integrity of the H. pylori outer and inner membranes using as fluorescent probe hydrophobic 1-N-phenyl-naphthylamine (NPN) and the release of aspartate aminotransferase. Further studies using a propidium iodide staining method assessed whether hLYS could increase cell permeability and promote cell absorption. Finally, we determined the effects of hLYS on the bactericidal dynamics and MPC of MNZ in H. pylori. Our findings indicate that hLYS could dramatically increase cell permeability, reduce the MPC of MNZ for H. pylori, and enhance its bactericidal dynamic activity, demonstrating that hLYS could reduce the probability of MNZ inducing resistance mutations.

19 April 2018 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
XZXiaolin Zhang
Xiaolin Zhang
AJAnmin Jiang
Anmin Jiang
BQBanghua Qi
Banghua Qi
HYHao Yu
Hao Yu
YXYouyi Xiong
Youyi Xiong
JWJianfei Wang
Jianfei Wang

Verified
Journal Article
Open access
PDF file
XZXiaolin Zhang
Xiaolin Zhang
HYHao Yu
Hao Yu
YXYou-Yi Xiong
You-Yi Xiong
MSMA Shitang
MA Shitang
LZLei Zhao
Lei Zhao
SSShi-Feng She
Shi-Feng She
Hepatocellular carcinoma (HCC) is a serious healthcare problem worldwide because of its increasing morbidity and high mortality rates. However, our understanding of the mechanism of liver tumorigenesis remains incomplete. We report the expression of myosin light chain kinase (MLCK) in the livers of rats with diethylnitrosamine (DENA)-induced HCC and investigated the correlation between MLCK and liver tumorigenesis by observing the expression of MLCK in a rat model of HCC. HCC was induced in rats by an intraperitoneal injection of DENA, and resveratrol-treated rats were orally administered resveratrol with 50 mg/kg body weight/day. The livers of rats were excised after 20 weeks and immersed in 10% formaldehyde prior to immunohistochemical and Western blot analyses for determining the level of MLCK expression. These analyses indicated that the MLCK expression was higher in the livers of HCC rats than in normal and resveratrol-treated rats. High level of MLCK expression was responsible for proliferation and anti-apoptotic effects. However, resveratrol down-regulated the expression of MLCK, which induced cell apoptosis and inhibited liver tumorigenesis in rats with DENA-induced HCC. Our results suggest that the over expression of MLCK may be related to the development of liver tumorigenesis.

1 February 2013 in Complementary Therapies in Medicine
Verified
Journal Article
Closed access
SMShitang Ma
Shitang Ma
CFCheng-Tao Feng
Cheng-Tao Feng
XZXiaolin Zhang
Xiaolin Zhang
GDGuo-Liang‘ Dai
Guo-Liang‘ Dai
CLChangyin Li
Changyin Li
HYHao Yu
Hao Yu

3 February 2010 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
XZXiaolin Zhang
Xiaolin Zhang
WSWeide Shen
Weide Shen
YLYe Lu
Ye Lu
XZXiaojian Zheng
Xiaojian Zheng
RXRenyu Xue
Renyu Xue
CGChengliang Gong
Chengliang Gong

10 May 2017 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
XZXiaolin Zhang
Xiaolin Zhang
AJAnmin Jiang
Anmin Jiang
GWGuisheng Wang
Guisheng Wang
HYHao Yu
Hao Yu
BQBanghua Qi
Banghua Qi
JWJianfei Wang
Jianfei Wang